79 related articles for article (PubMed ID: 25623955)
41. Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor.
Fujii T; Koshikawa K; Nomoto S; Okochi O; Kaneko T; Inoue S; Yatabe Y; Takeda S; Nakao A
J Hepatol; 2004 Jul; 41(1):104-11. PubMed ID: 15246215
[TBL] [Abstract][Full Text] [Related]
42. Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development.
Hatano S; Kimata K; Hiraiwa N; Kusakabe M; Isogai Z; Adachi E; Shinomura T; Watanabe H
Glycobiology; 2012 Sep; 22(9):1268-77. PubMed ID: 22692047
[TBL] [Abstract][Full Text] [Related]
43. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
44. Focal adhesion kinase (FAK) siRNA inhibits human hypertrophic scar by suppressing integrin α, TGF-β and α-SMA.
Chen R; Zhang Z; Xue Z; Wang L; Fu M; Lu Y; Bai L; Zhang D; Fan Z
Cell Biol Int; 2014 Jul; 38(7):803-8. PubMed ID: 24523242
[TBL] [Abstract][Full Text] [Related]
45. Decreased expression of beta1-integrin and focal adhesion kinase in epithelial cells may initiate involution of mammary glands.
McMahon CD; Farr VC; Singh K; Wheeler TT; Davis SR
J Cell Physiol; 2004 Aug; 200(2):318-25. PubMed ID: 15174102
[TBL] [Abstract][Full Text] [Related]
46. The diagnostic value of serum lncRNA CATG00000112921.1 as a marker of multiple myeloma.
Gao J; Qu J; Xiao B; Huang Q; Zhu C; Dai Z; Wu K; Li L; Zeng T
Curr Probl Cancer; 2024 Feb; 48():101057. PubMed ID: 38070464
[TBL] [Abstract][Full Text] [Related]
47. Identification of Novel Copy Number Variations of VCAN Gene in Three Chinese Families with Wagner Disease.
Li S; Li M; Sun L; Zhao X; Zhang T; Huang L; Huang S; Chen C; Wang Z; Ding X
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32854301
[TBL] [Abstract][Full Text] [Related]
48. Context-dependent bioactivity of versican fragments.
Timms KP; Maurice SB
Glycobiology; 2020 May; 30(6):365-373. PubMed ID: 31651027
[TBL] [Abstract][Full Text] [Related]
49. Emerging biomarkers in Multiple Myeloma: A review.
Gupta N; Sharma A; Sharma A
Clin Chim Acta; 2020 Apr; 503():45-53. PubMed ID: 31901479
[TBL] [Abstract][Full Text] [Related]
50. Pan-cancer analysis of the oncogenic role of the core osteosarcoma gene VCAN in human tumors.
Zhou H; Lu D; Yu D; Luo C; Xie K; Ma H; Li S; Liang J; Wei F; Chen L; Luo D; Wang W; Wei J
Am J Transl Res; 2023; 15(9):5556-5573. PubMed ID: 37854213
[TBL] [Abstract][Full Text] [Related]
51. The role of phosphatase and tensin homolog deleted on chromosome 10 and focal adhesion kinase in aggressive multiple myeloma.
Lin Y; Gertz MA
Leuk Lymphoma; 2012 Jun; 53(6):1021-2. PubMed ID: 22220917
[No Abstract] [Full Text] [Related]
52. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
Hope C; Foulcer S; Jagodinsky J; Chen SX; Jensen JL; Patel S; Leith C; Maroulakou I; Callander N; Miyamoto S; Hematti P; Apte SS; Asimakopoulos F
Blood; 2016 Aug; 128(5):680-5. PubMed ID: 27259980
[TBL] [Abstract][Full Text] [Related]
53. Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer.
Chang W; Zhu J; Yang D; Shang A; Sun Z; Quan W; Li D
Respir Res; 2023 May; 24(1):140. PubMed ID: 37259101
[TBL] [Abstract][Full Text] [Related]
54. Versican: A Dynamic Regulator of the Extracellular Matrix.
Islam S; Watanabe H
J Histochem Cytochem; 2020 Nov; 68(11):763-775. PubMed ID: 33131383
[TBL] [Abstract][Full Text] [Related]
55. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
Gupta N; Kumar R; Seth T; Garg B; Sharma A
RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618
[TBL] [Abstract][Full Text] [Related]
57. Differentially expressed genes
Jiang K; Liu H; Xie D; Xiao Q
Oncol Lett; 2019 Mar; 17(3):3191-3202. PubMed ID: 30867749
[TBL] [Abstract][Full Text] [Related]
58. Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.
Asimakopoulos F; Hope C; Johnson MG; Pagenkopf A; Gromek K; Nagel B
J Leukoc Biol; 2017 Aug; 102(2):265-275. PubMed ID: 28254840
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
